PATENT CLAIM ANALYSIS

Application Number: 15960759
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "264110"]

Abstract:
Novel azaquinazoline carboxamide derivatives of formula (I) wherein W 1 , W 2 , W 3 , W 4 , R 1 , R 2 , R 3  and m which are defined above, are p70S6K inhibitor, and can be employed, inter alia, for the treatment of hyperproliferative disorders.

Claim (Index 19):
The method according to  claim 18 , wherein the disease is selected from the group of hyperproliferative disorders, cancer, metastases, tumors, angiogenesis disorders, tumor angiogenesis, benign hyperplasia, hemangioma, glioma, melanoma, Kaposi's sarcoma, prostate diseases related to vasculogenesis or angiogenesis, inflammation, pancreatitis, retinopathy, retinopathy of prematurity, diabetic retinopathy, diabetes, pain, restenosis, psoriasis, eczema, scleroderma and age-related macular degeneration.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.55556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15227638', '14432618', '14432316', '14105974', '15277479']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8259257268619936
- 35 USC 102 Novelty (BERT): 0.545294491516046
- Combined Prediction Score: 0.7978626033273989
- Mean Citation Score: 365.420782
- Max Citation Score: 434.38058
- Similarity Product: 221.239217917608

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test